TickerKhojFMCG & Food · Household/Personal Care · NSE: JYOTHYLAB · data 2026-11-01
Jyothy Labs Limited
In plain words
Price: 46.1% below its 52-week high of ₹319.
Delivery: 49.0% of traded shares were kept for delivery over the last 10 sessions, against 49.3% over the last 60.
Latest results: a net profit of ₹48 cr for the quarter ended Jun 2026 (-50.8% on the same quarter a year earlier).
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹2,966 cr |
| Net profit (last 12 months) | ₹284 cr |
| Sales growth, 3 years (yearly) | 5.6% |
| Profit growth, 3 years (yearly) | 11.6% |
At a glance
Promoters 62.9% (unchanged in a year), pledged 0.0%, institutions 24.3%.
P/E 22.2, dividend yield 2.0%. Price relative to earnings and book value (low is cheaper, not better).
ROE 18.3%, ROCE 23.8%, operating margin 11.0%: how much profit it earns on the money it uses.
Debt/equity 0.03, Profit growth 11.6% and sales growth 5.6% a year over 3 years.
Ratings use fixed thresholds on the latest reported figures. They describe the numbers and are not a recommendation.
Strengths and limitations
- Virtually debt-free (debt/equity 0.1 or less).
- High return on equity (18.3%).
- Pays a dividend yielding 2.0%.
None flagged by these rules.
Picked automatically from the latest reported figures with fixed rules; check the company's filings before relying on them.
Latest results in brief (Q1 FY27)
JYOTHYLAB Q1 FY27 results (standalone figures, as filed on NSE).
Revenue was ₹773.4 crore, up 3% YoY and up 7.8% QoQ.
Net profit was ₹47.64 crore, down 50.8% YoY and down 29.4% QoQ.
Operating margin was 8.4% (16.5% a year ago).
EPS was ₹1.3, down 50.8% YoY and down 29.3% QoQ.
JYOTHYLAB के Q1 FY27 नतीजे (स्टैंडअलोन आंकड़े, NSE पर दाखिल)।
राजस्व: ₹773.4 करोड़; पिछले साल की तुलना में 3% की बढ़त, पिछली तिमाही की तुलना में 7.8% की बढ़त।
शुद्ध मुनाफ़ा: ₹47.64 करोड़; पिछले साल की तुलना में 50.8% की गिरावट, पिछली तिमाही की तुलना में 29.4% की गिरावट।
ऑपरेटिंग मार्जिन: 8.4% (एक साल पहले 16.5%)।
EPS: ₹1.3; पिछले साल की तुलना में 50.8% की गिरावट, पिछली तिमाही की तुलना में 29.3% की गिरावट।
JYOTHYLABના Q1 FY27 પરિણામો (સ્ટેન્ડઅલોન આંકડા, NSE પર ફાઇલ કરેલા).
આવક (રેવન્યુ): ₹773.4 કરોડ; ગયા વર્ષની સરખામણીએ 3% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 7.8% વધારો.
ચોખ્ખો નફો: ₹47.64 કરોડ; ગયા વર્ષની સરખામણીએ 50.8% ઘટાડો, ગયા ક્વાર્ટરની સરખામણીએ 29.4% ઘટાડો.
ઓપરેટિંગ માર્જિન: 8.4% (એક વર્ષ પહેલાં 16.5%).
EPS: ₹1.3; ગયા વર્ષની સરખામણીએ 50.8% ઘટાડો, ગયા ક્વાર્ટરની સરખામણીએ 29.3% ઘટાડો.
Written from the filed numbers. Not a recommendation.
Smart-money activity
14/100 · Weak over the last ~60 sessions, data 2026-10-30
- Delivery vs usual 0/30: Delivery 43.8% over the last 20 sessions vs 49.4% in the 40 before (0.89x); shares delivered per day 0.23x usual; 0 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 6/15: 0 insider buy days (promoter group among them) and 1 SAST acquisition day in 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 3/15: 2 schemes hold it, about ₹32 cr in all (as of 2026-09-30). Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Story so far
● Insider ● Dividend ● Results
- 24 Sept 26Insider SAST disclosure: Nalanda India Equity Fund Ltd acquired 31,02,384 shares -1.6% next session
- 29 Jun 26Dividend Dividend ₹3.5 (ex-date) -4.4% next session
- 28 Aug 25Dividend Dividend ₹3.5 (ex-date) -0.3% next session
- 12 May 25Results Q4 FY25 results: net profit ₹77 cr -8.3% next session
From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.
Quarterly results (standalone)
| Quarter | Revenue | Net profit | Profit YoY | Op. margin | EPS ₹ |
|---|---|---|---|---|---|
| Jun 2026 | ₹773 cr | ₹48 cr | -50.8% | 8.4% | 1.3 |
| Mar 2026 | ₹717 cr | ₹68 cr | -12.3% | 13.5% | 1.84 |
| Dec 2025 | ₹740 cr | ₹81 cr | -7.2% | 15.0% | 2.21 |
| Sept 2025 | ₹736 cr | ₹88 cr | -16.4% | 16.1% | 2.39 |
Shareholding trend
| Holder | Sept 2026 | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|---|
| Promoters | 62.89% | 62.89% | 62.89% | 62.89% |
| Foreign institutions (FII) | 14.48% | 12.13% | 12.35% | 12.77% |
| Domestic institutions (DII) | 9.86% | 13.37% | 14.63% | 15.13% |
| Mutual funds | 8.00% | 12.03% | 13.15% | 13.73% |
| Retail investors | 10.23% | 9.65% | 8.12% | 7.52% |
| Number of shareholders | 2,48,936 | 2,47,104 | 2,33,314 | 2,23,801 |
Common questions
What was Jyothy Labs Limited's latest quarterly profit?
Jyothy Labs Limited reported a net profit of ₹48 cr for the quarter ended Jun 2026 (-50.8% on the same quarter a year earlier), on revenue of ₹773 cr.
How much do promoters hold in Jyothy Labs Limited?
Promoters held 62.89% of Jyothy Labs Limited at the end of Sept 2026, with 0.00% of promoter shares pledged.
Is Jyothy Labs Limited debt-free?
Its latest reported debt-to-equity ratio is 0.03, which is very low.
What is Jyothy Labs Limited's P/E ratio?
About 22.2, based on the last 12 months' earnings and a price of ₹171.91 (data 2026-11-01).
What is the 52-week high and low of Jyothy Labs Limited?
The 52-week high is ₹319 and the 52-week low is ₹171.
Mutual funds holding Jyothy Labs Limited
From the monthly portfolios of the fund houses the site reads, as of 2026-09-30. 2 schemes holding about ₹32 cr; funds that hold it outside their top holdings may not be listed.
| Scheme | Fund house | % of fund | Value |
|---|---|---|---|
| SBI Consumption Opportunities Fund | SBI Mutual Fund | 1.06% | ₹28 cr |
| SBI Long Term Advantage Fund - Series VI | SBI Mutual Fund | 1.51% | ₹4 cr |
Compared with similar companies
| Company | Price | Market cap | P/E | P/B | ROE | ROCE | Debt/eq. | 1-yr return |
|---|---|---|---|---|---|---|---|---|
| Jyothy Labs Limited | ₹171.91 | ₹6,318 cr | 22.2 | — | 18.3% | 23.8% | 0.03 | -46.5% |
| Gillette India Limited | ₹7,094.5 | ₹23,085 cr | 34.6 | — | 66.4% | 81.3% | 0 | -23.1% |
| Procter & Gamble Hygiene & Health Care Ltd. | ₹6,927.5 | ₹22,253 cr | 28.4 | — | 114.9% | 134.7% | 0 | -48.4% |
| Emami Limited | ₹365.3 | ₹15,800 cr | 21.3 | — | 27.6% | 27.5% | 0.06 | -32.7% |
| Galaxy Surfactants Ltd. | ₹2,160.4 | ₹7,516 cr | 21.7 | — | 10.5% | 12.7% | 0.09 | -3.3% |
| Bajaj Consumer Care Limited | ₹378.05 | ₹4,853 cr | 19.7 | 5.5 | 25.3% | 26.1% | 0.02 | +40.5% |
Compare JYOTHYLAB with GILLETTE in detail →
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open JYOTHYLAB in TickerKhoj →